A single nucleotide polymorphism in the gene for GPR183 increases its surface expression on blood lymphocytes of patients with inflammatory bowel disease
Florian Ruiz(University Hospital of Geneva), Jean‐Benoît Rossel(Centre universitaire de médecine générale et santé publique, Lausanne), Luc Biedermann(University of Zurich), René Roth(University of Zurich), Pascal Juillerat(University of Bern), Aurélie Clottu(University of Lausanne), Benjamin Misselwitz(University of Zurich), Anja Moncsek(University Hospital of Zurich), Thomas Greuter(Ospedale regionale di Lugano), Gerhard Rogler(University Hospital of Zurich), Stephan Brand(Kantonsspital St. Gallen), Caroline Pot(University Hospital of Lausanne), Joachim C. Mertens(GastroZentrum Hirslanden Zürich), Emanuel Burri(Kantonsspital Baselland), Michael Christian Sulz(Kantonsspital St. Gallen), Annika Wyss(University of Zurich)
Cited by 12
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
|Journal of Crohn s and Colitis|2019|1.4k
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k
ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment
|Journal of Crohn s and Colitis|2019|1.1k